Registry for patients with obstructive sleep apnea treated with hypoglossal nerve stimulation
Official title: Hypoglossal Nerve Stimulation (HNS) Therapy in Patients With Obstructive Sleep Apnea (OSA): Belgian Registry
Run by University Hospital, Antwerp · NCT06332404 · Data updated 2026-11-12
This study is collecting information from patients with moderate to severe obstructive sleep apnea who are using a new device called Inspire to see how well it works and how it helps them over five years.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 99 Years |
| Sex | All |
| Enrollment | 225 (estimated) |
| Sponsor | University Hospital, Antwerp Academic / other |
| Locations | 2 sites (Edegem, Antwerp and 1 other locations) |
| Status | Recruiting |
| Started | April 18, 2024 |
| Main results expected | April 2034 |
| Study ends | April 2034 |
| Registry record updated | September 15, 2025 |
| Trial ID | NCT06332404 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this registry are adults aged 18 and older with moderate to severe obstructive sleep apnea who have not responded to or cannot tolerate traditional treatments like CPAP.
✕Probably not a fit
Patients with a body mass index over 32 kg/m² or those with specific anatomical issues that could hinder the effectiveness of the HNS therapy may not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This registry aims to collect data on patients with moderate to severe obstructive sleep apnea (OSA) who are treated with hypoglossal nerve stimulation (HNS) using the Inspire system in Belgium. Patients implanted with the Inspire device will be invited to participate, and data will be gathered during routine clinical visits over a five-year period. The collected data will include polysomnographic results, therapy usage, device performance, and patient-reported outcomes through various questionnaires. This observational approach allows for the assessment of the effectiveness and safety of HNS therapy in a real-world clinical setting.
Why it matters
Potential benefit: If successful, this registry could provide valuable insights into the long-term effectiveness and safety of hypoglossal nerve stimulation therapy for patients with obstructive sleep apnea.
How similar studies have gone: While this registry approach is not novel, similar studies have shown success in evaluating the effectiveness of hypoglossal nerve stimulation in other populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Any patient implanted with or receiving the Inspire HNS system and who is able to give informed consent is eligible to participate in the registry. A patient is eligible for HNS implantation if he/she meets the following criteria: * At least 18 years old at the time of implantation * The patient suffers from moderate to severe OSA (15 events/h ≤ AHI ≤ 65 events/h) * The patient has failed, not tolerated or has a contraindication for continuous positive airway pressure (CPAP) and/or mandibular advancement device (MAD) therapy * Absence of complete concentric collapse of the level of the soft palate during Drug-Induced Sleep Endoscopy (DISE) Exclusion Criteria: * Body mass index (BMI) \>32 kg/m². * Combined mixed and central AHI is more than 25% of the total AHI * Patients with complete concentric collapse at the level of the soft palate or any other anatomical deviation that could impede the proper functioning of HNS * Patients with severely impaired neurological control over the upper airway * Pregnancy * Surgery performed on the soft palate in the past three months before implantation.
Where it's running
-
Antwerp University Hospital
Edegem, Antwerp, Belgium Recruiting -
AZ Sint-Jan Brugge
Bruges, West-Vlaanderen, Belgium Recruiting
Study contacts
- Principal investigator: Olivier Vanderveken, MD, PhD — University Hospital, Antwerp
- Study coordinator: Dorine Van Loo, MSc
- Email: dorine.vanloo@uza.be
- Phone: +3238215780
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Daytime versus overnight titration for hypoglossal nerve stimulation
We will test whether a daytime sleep test works as well as an overnight sleep test to fine-tune hypoglossal nerve stimulation for people with moderate to severe obstructive sleep apnea.
-
Using a sleep medication to help people with obstructive sleep apnea tolerate CPAP
The trial will test whether giving the sleep medicine eszopiclone to people with obstructive sleep apnea (AHI ≥10/hour) helps them stick with CPAP and improves thinking skills.
-
Investigating the link between obstructive sleep apnea and pulmonary hypertension
This study looks at how common sleep apnea is in adults with pulmonary hypertension and how it affects their health.
-
Multimodal Deep Learning to Predict Sleep Apnea Severity from SpO2 and Ballistocardiography
Researchers are testing a smart-mattress-based method that uses SpO2 and ballistocardiography data to predict sleep apnea severity in adults undergoing overnight sleep study.
-
Nightly wearable monitoring with at-home submental electrical stimulation for sleep apnea
This pilot test checks whether wearing a ring sensor at night and doing a 4-week at-home submental electrical stimulation is feasible for adults with obstructive sleep apnea and looks at changes in sleep metrics.
-
Functional capacity and muscle function in adults with obstructive sleep apnea
This study tests how obstructive sleep apnea affects respiratory and peripheral muscle strength, endurance, and upper‑extremity function compared with healthy adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.